Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RBC Irradiation, Anemia and Gut Injury

NCT: NCT02741648 · COMPLETED

NCT IDNCT02741648
StatusCOMPLETED
Start Date2016-07
Completion2026-02-19
SponsorEmory University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this trial is to study the effect that anemia and red blood cell (RBC) transfusions have on oxygen levels in the digestive tracts of extremely low birth weight (ELBW) infants and to look for possible markers in a baby's blood, urine and/or stool that may lead to a better understanding of what makes an ELBW infant at risk for digestive tract problems such as necrotizing enterocolitis.

Frequently Asked Questions

What is RBC Irradiation, Anemia and Gut Injury?

RBC Irradiation, Anemia and Gut Injury is a clinical trial registered under NCT02741648. Current status: COMPLETED.

What is the status of NCT02741648?

The current status of NCT02741648 (RBC Irradiation, Anemia and Gut Injury) is: COMPLETED.

When did RBC Irradiation, Anemia and Gut Injury start?

RBC Irradiation, Anemia and Gut Injury started on 2016-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.